COMPANY

Sarcomatrix Therapeutics

Keywords: Duchenne muscular dystrophy

Location: Reno, NV · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Aug 22, 2025 Raise Private equity round: $300,000 (total, as published), announced Aug 22, 2025. Source: company's own press page. source ↗
Jan 7, 2025 Partnership Partnership / licensing announced Jan 7, 2025. Source: company's own press page. source ↗

Raised: $300K. Last 2 years.

Aug 22, 2025 Private equity round: $300,000 (total, as published), announced Aug 22, 2025. Source: company's own press page. source ↗
Jan 7, 2025 Partnership / licensing announced Jan 7, 2025. Source: company's own press page. source ↗